| 标题 |
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2+ breast cancer that limits trastuzumab deruxtecan efficacy |
| 网址 | |
| DOI | |
| 其它 |
期刊:Nature cancer 作者:Dong Hu; Xiaoshuang Lyu; Zheqi Li; Prasanna Ekambaram; Anushka Dongre; et al 出版日期:2025-06-27 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)